Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | TRPM5 | Q9NZQ8 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | HTR5A | P47898 | 1/20 | 0.32 |
| ▸ | AVPR1A | P37288 | 4/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28207585 | 1.00 | ADRA2A (0.36) | ADRA2AMETAP1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL29364253 | 1.00 | ADRA2A (0.36) | ADRA2AMETAP1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL28207065 | 1.00 | ADRA2A (0.36) | ADRA2AMETAP1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL31012300 | 0.86 | ADRA2A (0.39) | ADRA2AALDH1A1LMNACYP3A4HTT | |
| SCHEMBL30441385 | 0.86 | ADRA2A (0.39) | ADRA2AALDH1A1LMNACYP3A4HTT | |
| SCHEMBL20165806 | 0.86 | ADRA2A (0.39) | ADRA2AALDH1A1LMNACYP3A4HTT | |
| SCHEMBL20165771 | 0.86 | ADRA2A (0.46) | ADRA2AALDH1A1CYP3A4DRD2DRD1 | |
| SCHEMBL11532437 | 0.82 | LMNA (0.38) | ADRA2AMETAP1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL20584781 | 0.81 | ADRA2A (0.35) | ADRA2AMETAP1TRPM5HTR5ADPP8 | |
| SCHEMBL30834260 | 0.81 | ADRA2A (0.35) | ADRA2AMETAP1TRPM5HTR5ADPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50800-E1 | Pro-fragrance compounds | FIRMENICH SA (CH) | 2026-02-17 | — | — | US | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| US-20250186646-A1 | Use of Volatile Compositions to Limit or Eliminate Perception of Fecal Malodour | FIRMENICH SA (CH) | 2025-06-12 | — | — | US | claimed |
| US-20250134790-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2025-05-01 | — | — | US | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| US-20250009924-A1 | Indane Derivatives for Malodor Counteraction | FIRMENICH SA (CH) | 2025-01-09 | — | — | US | claimed |
| EP-4218837-B1 | VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH & CIE (CH) | 2024-11-27 | — | — | EP | claimed |
| US-20240238177-A1 | USE OF VOLATILE COMPOUNDS TO MODULATE THE PERCEPTION OF FLORAL MUGUET | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | claimed |
| WO-2024133645-A1 | ANTI-DANDRUFF COMPOSITIONS | FIRMENICH SA (CH) | 2024-06-27 | — | — | WO | claimed |
| EP-2760983-B1 | FLORAL PERFUMING COMPOSITIONS AS SUBSTITUTES FOR LILIAL | FIRMENICH & CIE (CH) | 2015-06-17 | — | — | EP | claimed |
| WO-2014202416-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH SA (CH) | 2014-12-24 | — | — | WO | claimed |
| US-20140234244-A1 | FLORAL PERFUMING COMPOSITIONS AS SUBSTITUTES FOR LILIAL® | FIRMENICH SA (CH) | 2014-08-21 | — | — | US | claimed |
| EP-2760983-A1 | FLORAL PERFUMING COMPOSITIONS AS SUBSTITUTES FOR LILIAL | Firmenich SA (CH) | 2014-08-06 | — | — | EP | claimed |
| EP-2694633-A1 | FORMULATIONS WITH A LONG-LASTING FLORAL FRAGRANCE EXCLUDING 4-(4-HYDROXY-4- METHYLPENTYL)-3-CYCLOHEXENECARBOXALDEHYDE | Beiersdorf AG (DE) | 2014-02-12 | — | — | EP | claimed |
| WO-2013045301-A1 | FLORAL PERFUMING COMPOSITIONS AS SUBSTITUTES FOR LILIAL® | FIRMENICH SA (CH) | 2013-04-04 | — | — | WO | claimed |
| WO-2012136651-A1 | FORMULATIONS WITH A LONG-LASTING FLORAL FRAGRANCE EXCLUDING 4-(4-HYDROXY-4- METHYLPENTYL)-3-CYCLOHEXENECARBOXALDEHYDE | BEIERSDORF AG (DE) | 2012-10-11 | — | — | WO | claimed |
| EP-1022265-B1 | 2-Indanemethanol derivatives and their use as perfuming ingredients | FIRMENICH & CIE (CH) | 2003-03-26 | — | — | EP | claimed |
| US-6323173-B1 | COMPOUNDS WHICH DEVELOP FRESH, HUMIC, VERY PLEASANT FRAGRANCE OF LILY OF THE VALLEY TYPE; GOOD STABILITY AND EXCELLENT TENACITY | FIRMENICH SA (CH) | 2001-11-27 | — | — | US | claimed |
| EP-1022265-A1 | 2-Indanemethanol derivatives and their use as perfuming ingredients | FIRMENICH SA (CH) | 2000-07-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009924-A1 | Indane Derivatives for Malodor Counteraction | MAL2, MTNR1A, LPO | ADRA2A 94/4885METAP1 779/4885ALDH1A1 150/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | ADRA2A 402/4885METAP1 2823/4885ALDH1A1 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.